← All trials
NCT01759810
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2012
- Primary completion
- Dec 1, 2015
- Completion date
- Dec 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- NeuroVita ClinicLead sponsor
- ZAO NeuroVita Clinic of Interventional and Restorative Neurology and TherapyOverall official - principal investigator
- Blokhin's Russian Cancer Research CenterCollaborator
- Russian Foundation of Technological DevelopmentCollaborator
- The Serbsky State Scientific Center for Social and Forensic PsychiatryCollaborator
- SRC BioclinicumCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.